• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Sagaliam Acquisition Corp. (Amendment)

    2/14/24 1:49:11 PM ET
    $SAGA
    Blank Checks
    Finance
    Get the next $SAGA alert in real time by email
    SC 13G/A 1 lighthouse-saga123123a1.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*



    Sagaliam Acquisition Corp.

    (Name of Issuer)

     

    Class A common stock included as part of the units

    (Title of Class of Securities)

     

    78661R205

    (CUSIP Number)

     

     

    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    x Rule 13d-1(b)

    o Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No.  78661R205
     SCHEDULE 13G/A
    Page 2 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Lighthouse Investment Partners, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    91,683
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    91,683
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    91,683
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.80%
    12
    TYPE OF REPORTING PERSON
     
    IA

     


     

    CUSIP No.  78661R205
     SCHEDULE 13G/A
    Page 3 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    91,683
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    91,683
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    91,683
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.80%
    12
    TYPE OF REPORTING PERSON
     
    FI

     


     

    CUSIP No.  78661R205
     SCHEDULE 13G/A
    Page 4 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    LHP Ireland Fund Management Limited
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ireland
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0%
    12
    TYPE OF REPORTING PERSON
     
    FI
     


     

    CUSIP No.  G0230C124
     SCHEDULE 13G/A
    Page 5 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    MAP 501, a sub-trust of LMA Ireland
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ireland
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0%
    12
    TYPE OF REPORTING PERSON
     
    FI
     


     

    CUSIP No.  G0230C124
     SCHEDULE 13G/A
    Page 6 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    LMAP 910, a sub-fund of LMAP Ireland ICAV
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ireland
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    0
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0%
    12
    TYPE OF REPORTING PERSON
     
    FI
     


     

     

    CUSIP No. 78661R205
     SCHEDULE 13G/A
    Page 7 of 11 Pages

     

    Item 1.(a) Name of Issuer

    Sagaliam Acquisition Corp.

    Item 1.(b) Address of Issuer’s Principal Executive Offices

    1800 Avenue of the Stars, Suite 1475

    Los Angeles, CA 90067

    Item 2.(a) Name of Person Filing:

     

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”)

     

    i) Lighthouse Investment Partners, LLC (“Lighthouse”) 

    ii) MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC (“MAP 136”)

    iii) LHP Ireland Fund Management Limited (“LHP Ireland”)

    iv) MAP 501, a sub-trust of LMA Ireland (“MAP 501)

    v) LMAP 910, a sub-fund of LMAP Ireland ICAV (“LMAP 910“)

      

    This Statement relates to the Issuers shares of common stock (“Shares”) directly beneficially owned by MAP 136. Lighthouse serves as the investment manager of MAP 136. LHP Ireland serves as the manager to MAP 501 and LMAP 910. Because Lighthouse and LHP Ireland may be deemed to control MAP 136, MAP 501, LMAP 910, as applicable, Lighthouse and LHP Ireland may be deemed to beneficially own, and to have the power to vote or direct the vote of, and the power to direct the disposition of the Issuer’s Shares reported herein.

     

    Address of Principal Business Office:

    3801 PGA Boulevard, Suite 604, Palm Beach Gardens, FL 33410

    32 Molesworth Street, Dublin, D02 Y512, Ireland

     

    Citizenship:

    MAP 136 is a segregated portfolio of LMA SPC, a Cayman Islands segregated portfolio company. MAP 501 is a sub-trust of an Ireland umbrella unit trust. LMAP 910 is a sub-fund of an Irish collective asset-management vehicle. Lighthouse is a Delaware limited liability company. LHP Ireland is an Ireland limited company.

      

    Item 2.(d) Title of Class of Securities

    Class A common stock included as part of the units

     

    Item 2.(e) CUSIP No.:

    78661R205

     

    CUSIP No.  78661R205
     SCHEDULE 13G/A
    Page 8 of 11 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     

    CUSIP No. 78661R205
     SCHEDULE 13G/A
    Page 9 of 11 Pages

     

     

    Item 4. Ownership

    (a) Amount Beneficially Owned: As of December 31, 2023, Lighthouse Investment Partners, LLC and Map 136 may be deemed the beneficial owner of 91,683 Shares.

     

      (b) Percent of Class: As of December 31, 2023, Lighthouse Investment Partners, LLC and Map 136 may be deemed the beneficial owner of approximately 0.80% of Shares outstanding.

     

      (c) Number of shares to which the person has:

     

      (i) Sole power to vote or to direct the vote: 0

     

      (ii) Shared power to vote or to direct the vote: 91,683

     

      (iii) Sole power to dispose or to direct the disposition of: 0

     

      (iv) Shared power to dispose or to direct the disposition of 91,683

    (a) Amount Beneficially Owned: As of December 31, 2023, LHP Ireland, MAP 501, and LMAP 910 may be deemed the beneficial owner of 0 Shares.

     

      (b) Percent of Class: As of December 31, 2023, LHP Ireland, MAP 501, and LMAP 910 may be deemed the beneficial owner of approximately 0% of Shares outstanding.

     

      (c) Number of shares to which the person has:

     

      (i) Sole power to vote or to direct the vote: 0

     

      (ii) Shared power to vote or to direct the vote: 0.

     

      (iii) Sole power to dispose or to direct the disposition of: 0

     

      (iv) Shared power to dispose or to direct the disposition of 0.

    Item 5. Ownership of Five Percent or Less of a Class

    Not Applicable.

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

    Not Applicable.

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not Applicable.

    Item 8. Identification and Classification of Members of the Group

    Not Applicable.

    Item 9. Notice of Dissolution of Group 

    Not Applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
    CUSIP No. 78661R205
     SCHEDULE 13G/A
    Page 10 of 11 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2024

     

     

     

     

    Lighthouse Investment Partners, LLC

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Vice President
           
     

    MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    LHP Ireland Fund Management Limited

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    MAP 501, a sub-trust of LMA Ireland

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    LMAP 910, a sub-fund of LMAP Ireland ICAV

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           

     
    CUSIP No. 78661R205
     SCHEDULE 13G/A
    Page 11 of 11 Pages

     

    Exhibit I

     

    JOINT FILING STATEMENT

     

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: February 14, 2024

     

     

    Lighthouse Investment Partners, LLC

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Vice President
           
     

    MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    LHP Ireland Fund Management Limited

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    MAP 501, a sub-trust of LMA Ireland

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
     

    LMAP 910, a sub-fund of LMAP Ireland ICAV

           
      By:  /s/ Robert P. Swan
        Robert P. Swan, Director
           
    Get the next $SAGA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SAGA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SAGA
    SEC Filings

    View All

    SEC Form 25-NSE filed by Sagaliam Acquisition Corp.

    25-NSE - Sagaliam Acquisition Corp (0001855351) (Subject)

    4/9/24 10:30:08 AM ET
    $SAGA
    Blank Checks
    Finance

    Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits

    8-K - Sagaliam Acquisition Corp (0001855351) (Filer)

    3/7/24 9:38:34 AM ET
    $SAGA
    Blank Checks
    Finance

    SEC Form 10-Q filed by Sagaliam Acquisition Corp.

    10-Q - Sagaliam Acquisition Corp (0001855351) (Filer)

    3/6/24 9:45:42 PM ET
    $SAGA
    Blank Checks
    Finance

    $SAGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gld Sponsor Member, Llc

    3 - Sagaliam Acquisition Corp (0001855351) (Issuer)

    5/11/23 1:10:06 PM ET
    $SAGA
    Blank Checks
    Finance

    $SAGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sagaliam Acquisition Corp Launches Improved IPF Formula with Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical

    BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp ("SAGA", the "Company") (NASDAQ:SAGA) announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ("VIRO"), and the Bulgarian product development team, headed by Dr. Lachezar Ivanov and Harry Zhabilov, CSO, have developed a new IPF formula which combines a Vitamin C component with the existing patented compound. This product will be marketed as IPF Immune+ with Vit C. In addition, this new product will be available in both pill and lozenge form providing convenience and a more effective delivery for the users. The team has also begun production of a new slimming formula which will be added to the VIRO nutraceuti

    5/1/24 8:30:00 AM ET
    $SAGA
    Blank Checks
    Finance

    Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.

    NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC:ENZC), Biogenysis, Inc. (BGEN), and Virogentics, Inc. (VIRO) (together the "Parties"). ​Under this restructured agreement SAGA retains 100% ownership of VIRO, ITV-1, the nutraceutical products and license along with VIRO's other assets. This agreement transferred ownership of Biogenysis, Inc. ("BGEN") and it's IP, patents and associated asset being developed back to ENZC in exchange for a reduction of the price from $450,000,000 to $290,000,000 with the dividend of the purchase shares to come dir

    4/26/24 8:00:00 AM ET
    $SAGA
    Blank Checks
    Finance

    SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ

    New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", SAGAR") (the "Company") received a Nasdaq Hearing Withdrawal letter ("Notice") from the Listing Qualifications staff of the Nasdaq Stock Market LLC ("Nasdaq") on March 6, 2024. On May 26, 2023, Staff notified the Company that the market value of its listed securities had been below the minimum $50,000,000 required for continued listing as set forth in Listing Rule 5450(b)(2)(A) for the previous 30 consecutive trading days.1 Therefore, in accordance with Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until November 22, 2023 to regain compliance with the Rule. O

    3/7/24 9:35:00 AM ET
    $SAGA
    Blank Checks
    Finance

    $SAGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Sagaliam Acquisition Corp. (Amendment)

    SC 13G/A - Sagaliam Acquisition Corp (0001855351) (Subject)

    2/14/24 1:49:11 PM ET
    $SAGA
    Blank Checks
    Finance

    SEC Form SC 13G filed by Sagaliam Acquisition Corp.

    SC 13G - Sagaliam Acquisition Corp (0001855351) (Subject)

    2/14/24 12:16:06 PM ET
    $SAGA
    Blank Checks
    Finance

    SEC Form SC 13D filed by Sagaliam Acquisition Corp.

    SC 13D - Sagaliam Acquisition Corp (0001855351) (Subject)

    5/11/23 1:08:27 PM ET
    $SAGA
    Blank Checks
    Finance

    $SAGA
    Leadership Updates

    Live Leadership Updates

    View All

    SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AND APPOINTMENT OF INDEPENDENT DIRECTORS

    New York, NY, July 28, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received a delinquency notification letter ("Notice") from the Listing Qualifications staff of the Nasdaq Stock Market LLC ("Nasdaq") on July 25, 2023 due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the "Form 10-Q"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commissio

    7/28/23 5:00:00 PM ET
    $SAGA
    Blank Checks
    Finance

    SAGALIAM ACQUISITION CORP. ANNOUNCES RESIGNATION OF THOMAS W. NEUKRANZ AS CHIEF FINANCIAL OFFICER AND DIRECTOR

    New York, NY, May 11, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that Thomas W. Neukranz, its Chief Financial Officer and member of its Board of Directors had resigned effective May 7, 2023. There were no disagreements between the Company and Mr. Neukranz on any matter related to the Company's operations, financial reporting, policies or practices. About Sagaliam Acquisition Corp. We are a blank check company incorporated under the laws of the State of Delaware on March 31, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganizati

    5/11/23 1:01:00 PM ET
    $SAGA
    Blank Checks
    Finance

    $SAGA
    Financials

    Live finance-specific insights

    View All

    Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.

    NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC:ENZC), Biogenysis, Inc. (BGEN), and Virogentics, Inc. (VIRO) (together the "Parties"). ​Under this restructured agreement SAGA retains 100% ownership of VIRO, ITV-1, the nutraceutical products and license along with VIRO's other assets. This agreement transferred ownership of Biogenysis, Inc. ("BGEN") and it's IP, patents and associated asset being developed back to ENZC in exchange for a reduction of the price from $450,000,000 to $290,000,000 with the dividend of the purchase shares to come dir

    4/26/24 8:00:00 AM ET
    $SAGA
    Blank Checks
    Finance

    Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure

    Provides Updates on SAGA Transaction and on Virogentics, Inc. and Biogenysis, Inc. ProgressALLEN, TX / ACCESSWIRE / November 20, 2023 / Enzolytics, Inc. (OTC:ENZC) (https://enzolytics.com/"https://enzolytics.com/). Enzolytics, Inc. (the "Company") filed an amended December 31, 2022 OTC Annual Report and its delinquent September 30, 2023 OTC quarterly disclosure. The purpose of the amended OTC Annual Report filed today is to include the audited financial statements for December 31, 2022 and 2021. As part of the recently completed sale of the two operating subsidiaries, Virogenetics, Inc. ("VIRO") and Biogenysis, Inc. ("BGEN"), to Sagaliam Acquisition Corp. (NASDAQ:SAGA)("SAGA") post-closing d

    11/20/23 9:10:00 AM ET
    $SAGA
    Blank Checks
    Finance